This is the second installment of two-part series by the Messenger-Inquirer examining the use of opioid-based drugs in addiction treatment. Today’s installment explores the personal ...
WhiteSands Alcohol & Drug Rehab has published a new educational resource exploring the differences between Adderall and ...
As cannabis legalization spreads, new research reveals that the mental health risks tied to a cannabis addiction depend ...
Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...
North County HEAL Coalition’s Into Light Project is sparking conversations and trainings aimed at reducing stigma and ...
Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...
Researchers are testing whether GLP-1 receptor agonists, originally for diabetes and obesity, can reduce cravings and relapse in substance use disorders. The National Institute on Drug Abuse has ...
To learn more about our editorial approach, explore The Direct Message methodology. A class of drugs designed to manage blood sugar and shrink waistlines appears to be doing something researchers say ...
Opium is a highly addictive drug. It’s made from juice extracted from the unripe seed pods of opium poppy plants (the scientific name is Papaver somniferum). Opium is used to make a class of drugs ...
This change frees researchers to study cannabis products that most consumers encounter when buying medical marijuana – which ...
The social media ad for a 2-ounce tonic called "Feel Free" caught Melanie Clark's attention because it promised she could eliminate drinking from her life while still feeling a buzz.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results